Sweden
# |
Name |
Return on Capital Employed (ROCE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
67.63%
|
Dec. 31, 2023 | USD 3.64 | -2.31% |
|
Sweden |
|
2 |
35.77%
|
Dec. 31, 2023 | USD 52.33 | -2.11% |
|
Sweden |
|
3 |
26.09%
|
Dec. 31, 2023 | USD 18.98 | -4.07% |
|
Sweden |
|
4 |
20.69%
|
Dec. 31, 2023 | USD 19.20 | -5.48% |
|
Sweden |
|
5 |
20.49%
|
Dec. 31, 2023 | USD 2.25 | -17.68% |
|
Sweden |
|
6 |
12.26%
|
Dec. 31, 2023 | USD 0.21 | -4.72% |
|
Sweden |
|
7 |
8.94%
|
Dec. 31, 2023 | USD 2.77 | -4.78% |
|
Sweden |
|
8 |
8.49%
|
Dec. 31, 2023 | USD 2.53 | -0.42% |
|
Sweden |
|
9 |
7.78%
|
Dec. 31, 2023 | USD 3.53 | -1.01% |
|
Sweden |
|
10 |
7.49%
|
Dec. 31, 2023 | USD 0.79 | -7.19% |
|
Sweden |
|
11 |
7.43%
|
Dec. 31, 2023 | USD 13.28 | -2.29% |
|
Sweden |
|
12 |
7.40%
|
Dec. 31, 2023 | USD 29.22 | -3.00% |
|
Sweden |
|
13 |
6.91%
|
Dec. 31, 2023 | USD 8.44 | 1.06% |
|
Sweden |
|
14 |
6.46%
|
Dec. 31, 2023 | USD 4.60 | 0.04% |
|
Sweden |
|
15 |
5.75%
|
Dec. 31, 2023 | USD 20.58 | -5.59% |
|
Sweden |
|
16 |
5.21%
|
Dec. 31, 2023 | USD 18.49 | 0.08% |
|
Sweden |
|
17 |
4.94%
|
Dec. 31, 2023 | USD 3.19 | -1.80% |
|
Sweden |
|
18 |
4.82%
|
Dec. 31, 2023 | USD 3.55 | -2.70% |
|
Sweden |
|
19 |
2.44%
|
Dec. 31, 2023 | USD 41.47 | -0.80% |
|
Sweden |
|
20 |
-4.54%
|
Dec. 31, 2023 | USD 0.85 | -1.32% |
|
Sweden |
|
21 |
-6.06%
|
Dec. 31, 2023 | USD 1.59 | -2.74% |
|
Sweden |
|
22 |
-13.93%
|
Dec. 31, 2023 | USD 0.71 | 8.98% |
|
Sweden |
|
23 |
-15.99%
|
Dec. 31, 2023 | USD 0.18 | -3.03% |
|
Sweden |
|
24 |
-18.93%
|
Dec. 31, 2023 | USD 1.64 | -3.31% |
|
Sweden |
|
25 |
-22.89%
|
Dec. 31, 2023 | USD 19.80 | -1.20% |
|
Sweden |
|
26 |
-24.68%
|
Dec. 31, 2023 | USD 3.06 | 1.23% |
|
Sweden |
|
27 |
-24.88%
|
Dec. 31, 2023 | USD 2.43 | -5.44% |
|
Sweden |
|
28 |
-33.29%
|
Dec. 31, 2023 | USD 0.50 | -2.16% |
|
Sweden |
|
29 |
-38.35%
|
Dec. 31, 2023 | USD 0.39 | -4.99% |
|
Sweden |
|
30 |
-49.17%
|
Dec. 31, 2023 | USD 0.54 | -2.24% |
|
Sweden |
|
31 |
-50.96%
|
Dec. 31, 2023 | USD 0.13 | 0.88% |
|
Sweden |
|
32 |
-57.78%
|
Dec. 31, 2023 | USD 0.16 | -2.74% |
|
Sweden |
|
33 |
-62.30%
|
Aug. 31, 2023 | USD 1.49 | -4.08% |
|
Sweden |
|
34 |
-104.05%
|
Dec. 31, 2023 | USD 3.01 | -2.55% |
|
Sweden |
|
35 |
-105.92%
|
Dec. 31, 2023 | USD 0.19 | -8.49% |
|
Sweden |
|
36 |
-110.04%
|
Dec. 31, 2023 | USD 1.26 | -1.32% |
|
Sweden |
|
37 |
-125.04%
|
April 30, 2024 | USD 0.18 | -8.41% |
|
Sweden |
|
38 |
-125.44%
|
Dec. 31, 2023 | USD 0.16 | 9.53% |
|
Sweden |
The Healthcare company in Sweden with the highest Return on Capital Employed (ROCE) is Sleep Cycle AB (publ) (Stockholm Stock Exchange: SLEEP.ST) at 67.63%.
The Healthcare company in Sweden with the lowest Return on Capital Employed (ROCE) is Oncopeptides AB (publ) (Stockholm Stock Exchange: ONCO.ST) at -125.44%.
The top 10 Healthcare companies in Sweden by Return on Capital Employed (ROCE) are Sleep Cycle AB (publ), Camurus AB (publ), BioArctic AB (publ), CellaVision AB (publ), Genovis AB (publ.), ADDvise Group AB (publ), Magle Chemoswed Holding AB (publ), Careium AB (Publ), Arjo AB (publ) and Boule Diagnostics AB (publ).
The bottom 10 Healthcare companies in Sweden by Return on Capital Employed (ROCE) are Oncopeptides AB (publ), Biovica International AB (publ), SynAct Pharma AB, Nanologica AB (publ), Hansa Biopharma AB (publ), Diamyd Medical AB (publ), Ortivus AB (publ), Enzymatica AB (publ), Egetis Therapeutics AB (publ) and Iconovo AB (publ).